Lisa Geiselhart

470 total citations
11 papers, 407 citations indexed

About

Lisa Geiselhart is a scholar working on Molecular Biology, Immunology and Organic Chemistry. According to data from OpenAlex, Lisa Geiselhart has authored 11 papers receiving a total of 407 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 6 papers in Immunology and 2 papers in Organic Chemistry. Recurrent topics in Lisa Geiselhart's work include Immunotherapy and Immune Responses (4 papers), Advanced Biosensing Techniques and Applications (3 papers) and Signaling Pathways in Disease (2 papers). Lisa Geiselhart is often cited by papers focused on Immunotherapy and Immune Responses (4 papers), Advanced Biosensing Techniques and Applications (3 papers) and Signaling Pathways in Disease (2 papers). Lisa Geiselhart collaborates with scholars based in United States. Lisa Geiselhart's co-authors include Jeffrey Subleski, Kristin L. Komschlies, Jon M. Wigginton, Eilene Gruys, Robert H. Wiltrout, Timothy Back, Jong‐Wook Park, T A Wiltrout, Kunio Nagashima and Sherry Mou and has published in prestigious journals such as Journal of Clinical Investigation, The Journal of Immunology and Transplantation.

In The Last Decade

Lisa Geiselhart

10 papers receiving 398 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lisa Geiselhart United States 6 276 137 92 42 35 11 407
Ai Ikejiri Japan 5 247 0.9× 59 0.4× 115 1.3× 34 0.8× 24 0.7× 6 358
Kentaro Sumida Japan 9 458 1.7× 295 2.2× 100 1.1× 39 0.9× 16 0.5× 17 602
Julien Gagnon Canada 8 249 0.9× 193 1.4× 85 0.9× 38 0.9× 24 0.7× 10 384
C C Ting United States 12 309 1.1× 146 1.1× 94 1.0× 13 0.3× 49 1.4× 15 426
Asuka Kobayashi Japan 9 139 0.5× 172 1.3× 125 1.4× 54 1.3× 24 0.7× 15 359
Sita Andarini Indonesia 9 239 0.9× 213 1.6× 76 0.8× 43 1.0× 30 0.9× 37 468
Paula Dobosz Poland 8 196 0.7× 264 1.9× 164 1.8× 47 1.1× 47 1.3× 28 504
Yuchan Cai China 4 221 0.8× 170 1.2× 72 0.8× 27 0.6× 15 0.4× 6 325
Lijie Yin China 9 270 1.0× 157 1.1× 87 0.9× 31 0.7× 32 0.9× 16 431
Kazuko Tsuneoka Japan 11 176 0.6× 93 0.7× 132 1.4× 24 0.6× 38 1.1× 27 389

Countries citing papers authored by Lisa Geiselhart

Since Specialization
Citations

This map shows the geographic impact of Lisa Geiselhart's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lisa Geiselhart with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lisa Geiselhart more than expected).

Fields of papers citing papers by Lisa Geiselhart

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lisa Geiselhart. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lisa Geiselhart. The network helps show where Lisa Geiselhart may publish in the future.

Co-authorship network of co-authors of Lisa Geiselhart

This figure shows the co-authorship network connecting the top 25 collaborators of Lisa Geiselhart. A scholar is included among the top collaborators of Lisa Geiselhart based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lisa Geiselhart. Lisa Geiselhart is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Lorber, Marc I., et al.. (2002). Luminex labscreen mixed as a qualitative antibody screening assay. Human Immunology. 63(10). S104–S104. 4 indexed citations
2.
Lorber, Marc I., et al.. (2002). Antibody screening via luminex LABScreen. Human Immunology. 63(10). S103–S103. 2 indexed citations
3.
Geiselhart, Lisa, et al.. (2001). IL-7 Administration Alters the CD4:CD8 Ratio, Increases T Cell Numbers, and Increases T Cell Function in the Absence of Activation. The Journal of Immunology. 166(5). 3019–3027. 117 indexed citations
4.
Wigginton, Jon M., Eilene Gruys, Lisa Geiselhart, et al.. (2001). IFN-γ and Fas/FasL are required for the antitumor and antiangiogenic effects of IL-12/pulse IL-2 therapy. Journal of Clinical Investigation. 108(1). 51–62. 110 indexed citations
5.
Lorber, Marc I., et al.. (2001). HLA-DR typing via LABType and the Luminex LabMAP. 1. 144. 1 indexed citations
6.
Wigginton, Jon M., Eilene Gruys, Lisa Geiselhart, et al.. (2001). IFN-γ and Fas/FasL are required for the antitumor and antiangiogenic effects of IL-12/pulse IL-2 therapy. Journal of Clinical Investigation. 108(1). 51–62. 96 indexed citations
7.
Geiselhart, Lisa, et al.. (1997). The Cigarette Tar Componentp-Benzoquinone Blocks T-Lymphocyte Activation by Inhibiting Interleukin-2 Production, but Not CD25, ICAM-1, or LFA-1 Expression. Toxicology and Applied Pharmacology. 143(1). 30–36. 23 indexed citations
8.
Li, Qing, et al.. (1996). Inhibition of Human T Lymphoblast Proliferation by Hydroquinone. Toxicology and Applied Pharmacology. 139(2). 317–323. 45 indexed citations
9.
Geiselhart, Lisa, David J. Conti, & Brian M. Freed. (1996). RO 31-8220, A NOVEL PROTEIN KINASE C INHIBITOR, INHIBITS EARLY AND LATE T CELL ACTIVATION EVENTS1. Transplantation. 61(11). 1637–1642. 6 indexed citations
10.
Geiselhart, Lisa, et al.. (1994). Computer-assisted analysis of PCR-SSP HLA-DR typings. Human Immunology. 40. 164–164. 1 indexed citations
11.
Gallichio, M, D Conti, Neil Lempert, et al.. (1994). Calcium-mediated induction of anergy in the Jurkat T-cell line.. PubMed. 26(6). 3458–9. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026